🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

link.springer.com/article/10.118… "Cultural perception of triatomine bugs and Chagas disease in Bolivia: a cross-sectional field study" finally published. Congratulations to Andrea Salm!

Congratulations to PD Dr. Andrea Chicca Andrea Chicca from @NCCR_TransCure GertschGroup for his great habilitation lecture!

Postdoctoral position and Two PhD positions in neuroscience, biochemistry and molecular pharmacology of the endocannabinoid system [academicpositions.com/ad/university-…]

Congrats to Sujay, Sara and Salome! Our new paper "Juniperonic Acid Biosynthesis is Essential in Caenorhabditis Elegans Lacking Δ6 Desaturase (fat-3) and Generates New ω-3 Endocannabinoids" is now online at: mdpi.com/2073-4409/9/9/…

🎓synendos has been awarded of an Innosuisse Innovation Grant in collaboration with the group of Prof. J. Gertsch GertschGroup at the Universität Bern! We look forward to characterize the new drug target of SERIs and to further explore the biology and pharmacology of SERIs 🔬

Our University of Bern NCCR TransCure Spin-off Synendos Therapeutics Raises CHF 20 Million in Series A Financing: nccr-transcure.ch/fileadmin/user… synendos.com/post/november-… Universität Bern ısılay vural TransCure synendos @unitectra

Congratulations! A huge success for synendos, a #unibern spin-off, which develops an innovative therapeutic approach to stress-related disorders. @NCCR_TransCure GertschGroup Andrea Chicca

Congrats to Sandras extremely successful PhD defence! We are all proud of you.

I am happy that our new truly interdisciplinary research on bioprospecting on Chagas disease is published in iScience: sciencedirect.com/science/articl… Congrats to Andrea and Sandhya and all collaborators for the hard work over many years! It started in Bolivia ...

Congratulations to Sandra on her recent published research on pepcans and hemopressin, great work: sciencedirect.com/science/articl… Schweizerischer Nationalfonds (SNF) IBMM_Uni Bern

Congratulations to Ines and Andrea and all co-authors (Engelhardt group) on the now published paper on our prototype SERI WOBE437 being effective in a mouse model of Multiple Sclerosis. @NCCR_TransCure synendos IBMM_Uni Bern pubs.acs.org/doi/10.1021/ac…

Congratulations to Sandra for seeing her research on pepcans and hemopressin published: Chhttps://www.sciencedirect.com/science/article/pii/S2212492621000245 Schweizerischer Nationalfonds (SNF) IBMM_Uni Bern

We are delighted to announce an extension to our Series A #financing with the addition of Ysios Capital to our syndicate of European investors. Press release: synendos.com/post/april-202… #CNS #endocannabinoid #biopharma #neurology #stressdisorders #neuropsychiatric

We are delighted to participate in the TOP 100 Swiss Startups Public Voting 2021. Public voting is open now! Support synendos Therapeutics by voting with your LinkedIn account here 👉 startup.ch/Synendos #TOP100SSU #Innovation #endocannabinoid #neuropsychiatric

We are honored to win the Top 100 Swiss Startup Public Voting Award 2021 in Biotech.🏆Thank you to all supporters of the @Synendos team and thanks @Venturelab for this great event! #TOP100SSU #endocannabinoids #biotech #CNS #neurology #neuropsychiatric #stressdisorders #teamwork

We’re hiring IBMM_Uni Bern For candidates wishing to apply for an Eccellenza Professorial Fellowship from the Swiss National Science Foundation (SNSF). more info: ibmm.unibe.ch/about_us/open_…

The IBMM has collected money to help a project by the Polish Ukrainian Foundation for the Development of Medicine to support newly established Kindergartens and work places for Ukrainian women who fled from the war in Ukraine to Lublin.

We are glad to announce that after almost 2 years of work, the learning path Vitaport in Bern, Elfenau parc, is open! It has been an exciting collaboration of @NCCR_TransCure, School of Design Bern & Biel Universität Bern (Fotos: SfG BB / Florian Spring, 2022), nccr-transcure.ch/vitaport-1

Raphael Mechoulam, survivor of the Nazi holocaust in Bulgaria, lifesaving researcher of cannabis & one of Israel's greatest scientists, has died at 92. I wrote about him several times. adn.com/nation-world/a…